Skip to main content
. 2018 Apr 12;136(5):553–556. doi: 10.1001/jamaophthalmol.2018.0920

Figure 1. Images From Patient 1 at Presentation and After Cessation of Antiprogrammed Cell Death Protein-1/Antiprogrammed Cell Death Ligand-1 (Anti-PD-1/Anti-PD-L1) Therapy.

Figure 1.

A and C, Images from patient 1 at initial presentation; B and D, Images from patient 1 after cessation of anti-PD-1/PD-L1 therapy. A, Fundus photography of the left eye showing choroidal effusions in all 4 quadrants; SD-OCT indicates spectral-domain optical coherence tomography.